PI3 kinase/mTOR inhibition increases sensitivity of ER positive breast cancers to CDK4/6 inhibition by blocking cell cycle re-entry driven by cyclinD1 and inducing apoptosis
Herrera-Abreu, M.T., Asghar, U.S., Elliot, R., Pearson, A., Nannini, M.A., Young, A., Sampath, D., Dowsett, M., Martin, L.A., Turner, N.
Published in Annals of oncology (01.05.2015)
Published in Annals of oncology (01.05.2015)
Get full text
Journal Article